Association between Adherence with an Atypical Antipsychotic and with Other Psychiatric Drugs in Patients with Bipolar Disorder.

Pharmacopsychiatry
Michael BauerPeter C Whybrow

Abstract

Using U.S. pharmacy and medical claims, medication adherence patterns of patients with serious mental illness suggest that adherence to atypical antipsychotics may be related to adherence to other prescription drugs. This study investigated whether adherence to an atypical antipsychotic was related to adherence to other prescribed psychiatric drugs using self-reported data from patients with bipolar disorder. Daily self-reported medication data were available from 123 patients with a diagnosis of bipolar disorder receiving treatment as usual who took at least 1 atypical antipsychotic over a 12-week period. Patients took a mean of 4.0±1.7 psychiatric drugs including the antipsychotic. The adherence rate for the atypical antipsychotic was compared to that for other psychiatric drugs to determine if the adherence rate for the atypical antipsychotic differed from that of the other psychiatric drug by at least ±10%. Of the 123 patients, 58 (47.2%) had an adherence rate for the atypical antipsychotic that differed from the adherence rate for at least 1 other psychiatric drug by at least±10%, and 65 (52.8%) patients had no difference in adherence rates. The patients with a difference took a larger total number of psychiatric drugs (p<...Continue Reading

References

Jul 29, 1998·European Journal of Clinical Pharmacology·L BjerrumJ Kragstrup
Jul 19, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sheldon Preskorn, Steve Werder
Apr 28, 2007·International Review of Psychiatry·Martha Sajatovic, Janis H Jenkins
Jan 19, 2008·Journal of Behavioral Medicine·Karen S Ingersoll, Jessye Cohen
Jul 11, 2009·Expert Review of Neurotherapeutics·Maurizio PompiliDavid Lester
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·John F SteinerRaymond O Estacio
Nov 27, 2010·Journal of Psychosomatic Research·Martha SajatovicGbenga Ogedegbe
Jun 27, 2012·The Australian and New Zealand Journal of Psychiatry·Michael BauerPeter C Whybrow
Sep 14, 2012·Journal of Managed Care Pharmacy : JMCP·Craig I ColemanTawfikul Alam
Apr 24, 2013·Journal of Clinical Psychopharmacology·Louisa G SylviaRoy H Perlis
Sep 13, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Robert OkwembaAndrew Wang
Oct 30, 2013·International Journal of Clinical Pharmacy·Audrey LehmannMarie Paule Schneider
Jan 1, 2013·International Journal of Bipolar Disorders·Michael BauerPeter C Whybrow
Jan 1, 2013·International Journal of Bipolar Disorders·Rita BauerMichael Bauer
Dec 24, 2015·Psychiatric Services : a Journal of the American Psychiatric Association·Jennifer B LevinMartha Sajatovic
Feb 19, 2016·Bipolar Disorders·Lars Vedel KessingPer Kragh Andersen
Jun 14, 2016·The Journal of Nervous and Mental Disease·Jennifer B LevinMartha Sajatovic
Jul 21, 2016·CNS Drugs·Jennifer B LevinMartha Sajatovic
Aug 6, 2017·European Journal of Clinical Pharmacology·Laís Lessa PantuzzaAdriano Max Moreira Reis
Mar 8, 2018·Pharmacopsychiatry·Gin S Malhi
May 2, 2018·International Journal of Bipolar Disorders·Maximilian PilhatschMichael Bauer
May 5, 2018·Advances in Therapy·Joanna P MacEwanFelicia M Forma
May 29, 2018·Research in Social & Administrative Pharmacy : RSAP·Fernanda S ToninVictoria Garcia-Cardenas
Dec 14, 2018·Therapeutic Advances in Psychopharmacology·Ibrahim JawadR Hamish McAllister-Williams
Mar 14, 2019·Journal of Mental Health·Jone BjornestadMarius Veseth
Jul 13, 2019·Journal of Affective Disorders·Vicki C FungAndrew A Nierenberg
Jul 23, 2019·International Journal of Bipolar Disorders·Leonardo TondoUNKNOWN International Group for Studies of Lithium (IGSLi)
Sep 5, 2019·International Journal of Bipolar Disorders·M BauerP C Whybrow
Sep 17, 2019·European Psychiatry : the Journal of the Association of European Psychiatrists·S A StrejilevichM R Goldfarb
Jan 7, 2020·International Journal of Bipolar Disorders·Ross J BaldessariniLeonardo Tondo
Apr 22, 2020·The American Journal of Psychiatry·Taeho Greg RheeSamuel T Wilkinson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here